Leader in the Italian ophthalmic market

The acquisition of Sooft in 2017, has enabled Fidia, who was active in the eye care segment in previous years, to re-gain market share and strengthen its position in this area, offering a wide array of products, such as eye drops, medical devices and food supplements.

Founded in 2000, Sooft is active in the ophthalmic sector, with a product portfolio that includes several well-known brands, and holds 27 patents.

Learn more about the Company, visit Sooft

Part of Fidia since 2017

Headquartered in Montegiorgio (Fermo, Italy)


Find out more about Fidia’s product portfolio:

Go to the website


Fidia Farmaceutici has a specific module dedicated to Pharmaco-Vigilance in order to promptly reporting of suspected adverse reactions. If you suspect that you have had an adverse reaction while taking one of our products or you have found defects

Key Business Areas

Fidia operates in numerous therapeutic areas, providing specific, innovative treatments for commonly occurring pathologies with major socio-economic impact, namely:

- joint care
- ophthalmology
- active wound care
- neuroscience
- aesthetic medicine